From the desk of Steve Strazza @Sstrazza

Our Top 10 Charts Report was just published.

In this weekly note, we highlight 10 of the most important charts or themes we're currently seeing in asset classes around the world.

China Bulls Take Charge

Chinese equities have emerged as some of the unlikely leaders among global markets. In the last month, China Internet ETF (KWEB) and iShares China Large-Cap ETF (FXI) have risen 31% and 19%, respectively. Meanwhile, Emerging Markets (EEM) are only up about 8.5% over the same period.

From the Desk of Kimmy Sokoloff

What a wipeout in the indices. We've almost retraced all of last week’s move.

The $SPX broke below 4,050, and it was downhill all day. 

The next new position in our Paid-to-Play portfolio is:

It's been impossible to ignore.

Equities and cyclicals have seen some modest gains off the lows, while growth areas and crypto markets have waned. In fact, by our calculations, this year has seen one of the greatest disparities in performance between growth and value.

You can see it when you compare something like Bitcoin or Ethereum against the Dow Jones Industrial Average.

Sure, crypto markets have been dragged down by the FTX contagion. Still, perhaps the bigger driver of this price action has been the macro flow out of long-duration growth assets (crypto included) and into traditional value areas.

We're talking industrials, materials, and, of course, energy stocks.

But let's not forget the broad picture.

From the Desk of Kimmy Sokoloff

The indices are pulling in this morning.

We're still in consolidation mode after last week's rally.

The largest insider transaction on today’s list is a Form 4 filed by Wayne P. Rothbaum, the president of Quogue Capital LLC.

The investment firm revealed a purchase worth $65 million in Iovance Biotherapeutics $IOVA.

Let me ask you this: In bear markets does it historically get easier and easier to find stocks making new all-time highs?

Where I grew up, new all-time highs, yet alone more and more of them every day, are not something that we normally see in bear markets.

And here we are. I can't remember the last time it was this easy to find stocks breaking out to new highs. And not just new 3-month highs or even 52-week highs.

Stocks are breaking out to new ALL-TIME Highs.

And not just in one or two sectors.

We're seeing it in Financials, Industrials, Technology, Energy, Healthcare, Staples, Telecom and more.

This is the weekly post that aggregates all the charts we put together throughout the week and organizes them all into one, easy to flip through deck.

It's the weekly commodity edition of What the FICC?

Today we're checking back on two recent trades from October -- coffee and orange juice.

Check it out!

From the desk of Steve Strazza @Sstrazza and Alfonso Depablos @AlfCharts

Our Hall of Famers list is composed of the 150 largest US-based stocks.

These stocks range from the mega-cap growth behemoths like Apple and Microsoft – with market caps in excess of $2T – to some of the new-age large-cap disruptors such as Moderna, Square, and Snap.

It has all the big names and more.

It doesn’t include ADRs or any stock not domiciled in the US. But don’t worry; we developed a separate universe for that which you can check out here.

The Hall of Famers is simple.

We take our list of 150 names and then apply our technical filters so the strongest stocks with the most momentum rise to the top.

Let’s dive right in and check out what these big boys are up to.

Here’s this week’s list:

Click table to enlarge view

We filter out any laggards that are down -5% or more relative to the S&P 500 over the trailing...

From the Desk of Ian Culley @IanCulley

Precious metals shine as the dollar drops.

It makes sense our bullish metal trades are working in this environment. But how are less dollar-sensitive contracts faring?

Let’s check back on two recent trades from October, coffee and orange juice.

First up is the orange juice futures contract:

OJ came within striking distance of our upside objective last month.

It’s now carving out a near-term top while posting a bearish momentum divergence – not the most bullish price action.

Regardless, I want to give OJ the benefit of the doubt as long as it holds above our 191 risk level. All bets are off if it breaks below that mark.

At the same time, selling a breakdown here does not appeal to me. The price memory below 191 has "chop-fest" written all over it!

And,...

From the Desk of Kimmy Sokoloff

After this morning’s dip lower, the $SPX mostly based around its 200-day moving average.

Overall, it was a tough week. We traded lower the first part of the week, and then came Powell...